University Hospital Centre, Sestre Milosrdnice

Zagreb 10000

1 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Crohn's Disease, First Line Non-Small Cell Lung Cancer, Follicular Lymphoma, Non-Small Cell Lung Cancer, Solid Tumor, Triple-Negative Breast Cancer, Triple-Negative Breast Neoplasms

Studies at this site

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — Recruiting now
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) — Stopped early
• A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Completed
• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) — Stopped early
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
• A Comparative Study Of PF-06439535 Plus Paclitaxel-Carboplatin And Bevacizumab Plus Paclitaxel-Carboplatin Patients With Advanced Non-Squamous NSCLC — Completed